BIOMAT Database Logo BIOMAT Database Logo

Aseptic meningitis associated with muromonab-CD3. 1991

W D Figg

UI MeSH Term Description Entries
D008582 Meningitis, Aseptic A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. (From Adams et al., Principles of Neurology, 6th ed, p745) Aseptic Meningitis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016853 Muromonab-CD3 Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3/Ti). Monoclonal Antibody OKT3,OKT3,Orthoclone OKT3,Muromonab CD3

Related Publications

W D Figg
Aseptic meningitis associated with muromonab-CD3.
December 1990, DICP : the annals of pharmacotherapy,
W D Figg
Aseptic meningitis associated with muromonab CD3 administration.
March 1989, DICP : the annals of pharmacotherapy,
W D Figg
Aseptic meningitis associated with muromonab-CD3 therapy.
October 1988, Clinical pharmacy,
W D Figg
Comment: muromonab CD3 aseptic meningitis.
September 1989, DICP : the annals of pharmacotherapy,
W D Figg
Aseptic meningitis and muromonab-CD3 therapy.
February 1991, DICP : the annals of pharmacotherapy,
W D Figg
Encephalopathy associated with muromonab-CD3.
August 1993, Clinical pharmacy,
W D Figg
Hearing loss associated with muromonab-CD3 therapy.
December 1988, Clinical pharmacy,
W D Figg
[Muromonab CD3].
May 2005, Nihon rinsho. Japanese journal of clinical medicine,
W D Figg
Muromonab-CD3.
June 1991, The Australian nurses' journal. Royal Australian Nursing Federation,
W D Figg
Muromonab CD3 (Orthoclone OKT3).
September 1995, The Journal of toxicological sciences,
Copied contents to your clipboard!